BBPvsARKGETF Comparison
VS
Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. Both ETFs have the same top 1 sector exposures: Healthcare. BBP is less expensive with a Total Expense Ratio (TER) of 0.34%, versus 0.75% for ARKG. BBP is up 28.37% year-to-date (YTD) with +$66M in YTD flows. ARKG performs better with 66.94% YTD performance, and +$289M in YTD flows. Run a side-by-side ETF comparison of BBP and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBP vs ARKG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/26/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP ARKG | -2.65%-8.61% | +5.62%+29.14% | +28.37%+66.94% | +38.01%+56.39% | +119.28%+111.97% | +100.33%-35.16% |
| Flows | BBP ARKG | -+$236M | +$26M+$250M | +$66M+$289M | +$78M+$262M | +$83M-$232M | +$76M-$1.81B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP ARKG | +28.32%+49.24% | +26.44%+44.32% | +24.98%+44.65% | +26.86%+46.82% |
| Max drawdown | BBP ARKG | -8.70%-17.81% | -9.59%-27.52% | -25.54%-46.41% | -37.61%-76.56% |
| Max drawdown duration | BBP ARKG | 68d21d | 48d126d | 292d882d | 586d1817d |
Trading data
BBP | ARKG | |
Last sale 10/27/2026 at 1:30 PM | $104.89 | $51.65 |
| Previous close 10/26/2026 | $102.33 | $48.72 |
| Consolidated volume 10/26/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexBBP | ARKG | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/27/2026 at 1:30 PM
Live
Closed
BBP | ARKG | |
|---|---|---|
| Last price | $104.89 | $51.65 |
| 1D performance | +2.50% | +6.01% |
| AuM | $127.99 M | $2.24 B |
| E/R | 0.34% | 0.75% |
Characteristics
BBP | ARKG | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | VIRTUS Investment Partners | Ark Investment |
| Benchmark | LifeSci Biotechnology Products Index | - |
| N° of holdings | 66 | 31 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | April 2, 2019 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBP
USA
85.98%
Other
14.02%
ARKG
USA
88.62%
Other
11.38%
Sectors
BBP
Healthcare
98.44%
Other
1.56%
ARKG
Healthcare
97.89%
Other
2.11%
Diversification
BBP
Total weight of top 15 holdings out of 15
31.08%
ARKG
Total weight of top 15 holdings out of 15
74.64%
Top 15 holdings
Data as of August 31, 2026
BBP
Moderna, Inc.
3.58%
Crinetics Pharmaceuticals, Inc.
2.94%
Omeros Corp.
2.49%
Iovance Biotherapeutics, Inc.
2.36%
Verastem, Inc.
2.15%
Precigen, Inc.
1.99%
Halozyme Therapeutics, Inc.
1.84%
Zai Lab Ltd.
1.82%
Kiniksa Pharmaceuticals International Plc
1.81%
Kura Oncology, Inc.
1.72%
BeOne Medicines Ltd.
1.70%
Rigel Pharmaceuticals, Inc.
1.69%
Nuvation Bio, Inc.
1.69%
ACADIA Pharmaceuticals, Inc.
1.67%
Protagonist Therapeutics, Inc.
1.65%
ARKG
10X Genomics, Inc.
9.58%
Twist Bioscience Corp.
9.13%
Tempus AI, Inc.
7.91%
CRISPR Therapeutics AG
6.10%
Personalis, Inc.
5.93%
Absci Corp.
4.88%
Natera, Inc.
4.06%
Illumina, Inc.
4.04%
Eli Lilly & Co.
3.86%
CareDx, Inc.
3.85%
Guardant Health, Inc.
3.81%
Beam Therapeutics, Inc.
3.56%
Compass Pathways Plc
3.17%
Recursion Pharmaceuticals, Inc.
2.44%
Adaptive Biotechnologies Corp.
2.32%
Frequently asked questions about BBP and ARKG
How have the BBP and ARKG ETFs performed in 2026?
As of October 26, 2026, BBP is up 28.37% year-to-date (YTD), while ARKG has returned 66.94%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or ARKG?
Year-to-date, the BBP ETF saw +$66M in flows, compared to +$289M for ARKG.
Which ETF is more volatile: BBP or ARKG?
Over the past year, BBP had a volatility of 26.44%, while ARKG experienced 44.32%.
Which ETF is bigger: BBP or ARKG?
As of October 26, 2026, BBP holds $127.99 M in assets under management (AUM), while ARKG manages $2.24 B.
What sectors do the BBP and ARKG ETFs invest in?
BBP leans toward sectors like Healthcare. Meanwhile, ARKG focuses on Healthcare.
What are the top holdings of the BBP ETF and ARKG ETF?
BBP top holdings include Moderna, Inc., Crinetics Pharmaceuticals, Inc. and Omeros Corp.. ARKG holds in its top three: 10X Genomics, Inc., Twist Bioscience Corp. and Tempus AI, Inc..
Which ETF is more diversified: BBP or ARKG?
BBP holds 66 securities with 31.08% of its assets in the top 15. ARKG has 31 securities and a top 15 weight of 74.64%.
Advertisement
Latest news about BBP & ARKG
The Weekly ETF Market Monitor (October 19-23, 2026)
October 26, 2026
ARKG
Biotech ETFs – Investing in Health Innovation
July 21, 2022
ARKG
Advertisement
Advertisement
